Board Meetings for GUFICBIO
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| GUFICBIO | Gufic Biosciences Limited | 14 Aug 2024 | GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business. | Board Meeting Intimation | |
| GUFICBIO | Gufic Biosciences Limited | 29 May 2024 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters | |
| GUFICBIO | Gufic Biosciences Limited | 29 May 2024 | GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Other business. | Board Meeting Intimation | |
| GUFICBIO | Gufic Biosciences Limited | 14 Feb 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2023 and other business matters | |
| GUFICBIO | Gufic Biosciences Limited | 14 Feb 2024 | GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Other business. | Board Meeting Intimation | |
| GUFICBIO | Gufic Biosciences Limited | 09 Nov 2023 | GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2023 and Other business. | Board Meeting Intimation | |
| GUFICBIO | Gufic Biosciences Limited | 09 Nov 2023 | Financial Results/Other business matters | To consider and approve the Standalone and Consolidated Unaudited Financial Results for the period ended September 30, 2023 and other business matters | |
| GUFICBIO | Gufic Biosciences Limited | 01 Sept 2023 | GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 01-Sep-2023 to consider and approve Fund raising/Other business. | Board Meeting Intimation | |
| GUFICBIO | Gufic Biosciences Limited | 01 Sept 2023 | Fund Raising/Other business matters | To consider Fund Raising and other business matters | |
| GUFICBIO | Gufic Biosciences Limited | 11 Aug 2023 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters | |
| GUFICBIO | Gufic Biosciences Limited | 11 Aug 2023 | GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 11-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2023 and ESOP/Other business. | Board Meeting Intimation | |
| GUFICBIO | Gufic Biosciences Limited | 29 May 2023 | GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend/Other business. | Board Meeting Intimation | |
| GUFICBIO | Gufic Biosciences Limited | 29 May 2023 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and recommendation of dividend, if any for the financial year 2022-23. | |
| GUFICBIO | Gufic Biosciences Limited | 11 Nov 2022 | Financial results | Gufic Biosciences Limited has informed the Exchange about Board Meeting to be held on 11-Nov-2022 to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022 | |
| GUFICBIO | Gufic Biosciences Limited | 11 Aug 2022 | Financial results | Gufic Biosciences Limited has informed the Exchange about Board Meeting to be held on 11-Aug-2022, inter alia, to consider and approve Unaudited Financial Results for the quarter ended June 30, 2022 |